Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SAT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HOMER3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATOX1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HSD17B11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PHPT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
S100A4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HDAC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LTB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DAPK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OBSCN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LAPTM4B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLX4IP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GJA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TACC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PCSK1N - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NKD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARL6IP5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on